About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Abbott’s Low-dose Antiretroviral for Children Receives FDA Approval

by Medindia Content Team on November 14, 2007 at 2:52 PM
Font : A-A+

Abbott’s Low-dose Antiretroviral for Children Receives FDA Approval

Abbott Laboratories on Monday announced that it has received FDA approval to market and sell a lower-dose version of its antiretroviral drug Kaletra for children, the Chicago Sun-Times reports.

The tablet will be available in the U.S. this month, Bloomberg/Chicago Tribune reports. Kaletra has been available in liquid form for children since 2000, but the company in August warned health care providers to be cautious in prescribing Kaletra to children after the death of an infant who received an accidental overdose of the drug, Bloomberg/Chicago Tribune reports.

Advertisement

The new, lower-dose tablets can be taken with or without food and do not require refrigeration, which is an important advantage in treating children in developing countries, Abbott said. The new tablet will cost $2,100 annually per patient in the U.S. and $250 per patient annually in developing countries, the company said. The company added that approval in the European Union is pending, and once approved, it intends to make the drug available in more than 150 countries.

"We are expecting" the first step toward approval in the E.U. soon, Julie Herlocker, a spokesperson for Abbott, said, adding the company has an agreement with European regulators to ship the drug if it is requested directly by medical personnel.
Advertisement

"HIV/AIDS continues to have a devastating impact globally, especially among the more than two million children living with the disease throughout the world," Scott Brun, divisional vice president for infectious disease development at Abbott, said, adding, "Abbott developed a lower-strength tablet formulation of Kaletra to give physicians an innovative treatment option to help curb the impact of HIV infection in children".

Source: Kaiser Family Foundation
LIN/P
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Height and Weight-Kids 

Recommended Reading
Prevention, Treatment & Control of HIV Infection
Encyclopedia section of medindia explains in brief about prevention, treatment and control of HIV .....
US FDA Approves First in New Class of HIV Drug
Pfizer's maraviroc, the first in a new class of HIV drugs formulated to stop HIV virus from ......
Abbott, FDA Warn About Overdose of Antiretroviral Drug in Children
Abbott's antiretroviral drug Kaletra to children after the death of an infant who received an ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use